REVVITY, INC Restructuring Costs
REVVITY, INC (RVTY) reported Restructuring Costs of $35.51 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-08-11
- REVVITY, INC restructuring costs for the quarter ending 2026-07-05 was $35.51M, a 216.95% increase year-over-year.
- REVVITY, INC restructuring costs for the quarter ending 2026-04-05 was $10.68M, a 229.58% increase year-over-year.
- REVVITY, INC restructuring costs for the quarter ending 2025-06-29 was $11.20M.
- REVVITY, INC restructuring costs for the quarter ending 2025-03-30 was $3.24M.
- REVVITY, INC restructuring costs for fiscal 2025 was $55.93M, a 220.45% increase from fiscal 2024.
- REVVITY, INC restructuring costs for fiscal 2024 was $17.45M, a 34.39% decline from fiscal 2023.
- REVVITY, INC restructuring costs for fiscal 2023 was $26.60M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 12 month |
|---|---|---|---|
| 2026-07-05 | $35.51M 10-Q · filed 2026-08-11 | $46.18M 10-Q · filed 2026-08-11 | |
| 2026-04-05 | $10.68M 10-Q · filed 2026-05-12 | ||
| 2025-12-28 | $55.93M 10-K · filed 2026-02-24 | ||
| 2025-06-29 | $11.20M 10-Q · filed 2026-08-11 | $14.44M 10-Q · filed 2026-08-11 | |
| 2025-03-30 | $3.24M 10-Q · filed 2026-05-12 | ||
| 2024-12-29 | $17.45M 10-K · filed 2026-02-24 | ||
| 2023-12-31 | $26.60M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |